Posts Tagged ‘regenerative medicine’

Right Turn: Small device packs big potential

Author: Stacey Johnson, 08/11/17

Whenever something sounds too good to be true, it usually is. The expression is used widely in a variety of contexts, one of which is as a warning to avoid being taken in by a scam or taken advantage of. Unfortunately, it applies to the stem cell field too. I am tempted to state that…Read more

BRM2017: State of the regenerative medicine industry

Author: Stacey Johnson, 08/09/17

Although new to the field of science communication, Nathan Holwell has been involved in a variety of research during his undergraduate career and now in his graduate career. He has done research in drug delivery, gene delivery, biomaterials and diagnostic devices. His graduate research at Queen’s University, where he is pursuing a PhD in Chemical…Read more

The “immunity saboteurs ” – otherwise known as T-cells

Author: Hamideh Emrani, 06/07/17

Did you know that a healthy person with a healthy lifestyle and diet might still end up being diabetic? That is certainly the case with those who have type 1 diabetes (T1D). In T1D, the patient’s body has lost the ability to produce insulin. Insulin is a hormone that acts like an agent and takes…Read more

A few good women: Engineering grads to watch

Author: Stacey Johnson, 05/30/17

Engineers Canada reports on student enrolment and graduations from Canadian universities and colleges. Data from 2015 show that undergraduate enrolment continues to increase year after year, a welcome trend for those of us who hire from these programs. This year’s newly capped and gowned crop of university students have wrapped up exams and are moving…Read more

Five regenerative medicine workshops to attend this summer

Author: Guest, 05/15/17

Amin Adibi is a biomedical engineer and a health data analyst at the University of British Columbia. His areas of interest include cell manufacturing and bioprocess optimization, clinical translation of cellular therapies, health outcomes and cost-effectiveness modelling. Amin has an MSc degree from University of Calgary, where he focused on developing adjuvant MSC-based therapies for…Read more

Right Turn: Health care solutions on demand through 3D printing

Author: Stacey Johnson, 04/21/17

3D printing is a topic we’ve covered before at Signals. It’s still hot and trendy, and still making the cut on top technology lists. Back in 2012, Chris Anderson, the former editor-in-chief of Wired, predicted that 3D printing “will be bigger than the web.” Given that good 3D printers are now cheap enough (US$150) to…Read more

Right Turn: Sightings of innovation in Canada

Author: Stacey Johnson, 04/14/17

If you are a knowledge worker, it may seem as though “innovation” is on everyone’s lips these days. First, Canadians saw Industry Canada renamed Innovation, Science and Economic Development when Prime Minister Trudeau unveiled his first cabinet. Then, Budget 2017, titled “building a strong middle class” could have had “the innovation budget” as its working…Read more

Enabling technologies are helping regenerative medicine to succeed

Author: Stacey Johnson, 04/11/17

Earlier this year, the University of Toronto’s Institute of Biomaterials and Biomedical Engineering (IBBME) published its Annual Report, chock full of impressive numbers about enrolment, new programs and research published by its esteemed faculty. (If you’re curious, you can read it for yourself.) In response, I summarized the regenerative medicine research here. But I only…Read more

Right Turn: The robots aren’t coming, they’re here

Author: Stacey Johnson, 03/31/17

via GIPHY Artificial Intelligence (AI) already permeates our culture and that’s only going to increase with time and advances to the technology. Some think this is good news, progress and inevitable while others, like Stephen Hawking for example, fear where AI could take us. AI is on my mind this week with the announcement that…Read more

From organ survival to organ revival – how patients can regenerate their own donor lung prior to surgery

Author: Holly Wobma, 03/22/17

For most areas of medicine, the supply of a treatment can easily meet demand (access issues aside). Need an antibody? A steroid? Millions of pills are manufactured every day. The case could not be more different for solid organ transplantation, for which the list of patients with end-stage organ failure vastly exceeds the number of…Read more